Clinical Trial Update: FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).

View source ↗

Summary

An update on a study investigating inflammation, lipid metabolism, blood pressure and organ damage in people with obesity and chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: Collegium Medicum w Bydgoszczy | Conditions: Obesity, Chronic Kidney Disease | Status: UNKNOWN